Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients

Biol Psychiatry. 1996 Oct 15;40(8):804-6. doi: 10.1016/0006-3223(96)00250-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Agoraphobia / diagnosis
  • Agoraphobia / drug therapy*
  • Agoraphobia / psychology
  • Arousal / drug effects
  • Benzodiazepinones / pharmacology*
  • Double-Blind Method
  • Female
  • Humans
  • Lactic Acid*
  • Male
  • Middle Aged
  • Pain Measurement
  • Panic Disorder / diagnosis
  • Panic Disorder / drug therapy*
  • Panic Disorder / psychology
  • Phenylurea Compounds*
  • Receptor, Cholecystokinin B
  • Receptors, Cholecystokinin / antagonists & inhibitors*
  • Receptors, Cholecystokinin / physiology

Substances

  • Benzodiazepinones
  • Phenylurea Compounds
  • Receptor, Cholecystokinin B
  • Receptors, Cholecystokinin
  • Lactic Acid
  • L 365260